In particular, T helper (Th) 17 cells, a subtype of lymphocytes differentiated from naive CD4+ T cells and producing interleukin (IL)-17, are considered potent inflammatory effectors in MS [5,6]. This evidence concerns the gene CD4 and myeloid sarcoma.